Search

Author/Creator Duquette, P.

1. Anti‐inflammatory disease‐modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study. (2nd November 2018)

Authors:
Lorscheider, J.; Kuhle, J.; Izquierdo, G.; Lugaresi, A.; Havrdova, E.; Horakova, D.; Hupperts, R.; Duquette, P.; Girard, M.; Prat, A.; Grand'Maison, F.; Grammond, P.; Sola, P.; Ferraro, D.; Trojano, M.; Ramo‐Tello, C.; Lechner‐Scott, J.; Pucci, E.; Solaro, C.; Slee, M.
Journal:
European journal of neurology
Issue:
Volume 26:Number 2(2019)
Page Start:
363
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. BREMSO: a simple score to predict early the natural course of multiple sclerosis. (25th March 2015)

Authors:
Bergamaschi, R.; Montomoli, C.; Mallucci, G.; Lugaresi, A.; Izquierdo, G.; Grand'Maison, F.; Duquette, P.; Shaygannejad, V.; Alroughani, R.; Grammond, P.; Boz, C.; Iuliano, G.; Zwanikken, C.; Petersen, T.; Lechner‐Scott, J.; Hupperts, R.; Butzkueven, H.; Pucci, E.; Oreja‐Guevara, C.; Cristiano, E.
Journal:
European journal of neurology
Issue:
Volume 22:Number 6(2015:Jun.)
Page Start:
981
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Fluctuations of MS births and UV‐light exposure. (12th September 2012)

Authors:
Verheul, F.; Smolders, J.; Trojano, M.; Lepore, V.; Zwanikken, C.; Amato, M. P.; Grand'Maison, F.; Butzkueven, H.; Marrosu, M.; Duquette, P.; Comi, G.; Izquierdo, G.; Grammond, P.; Lus, G.; Petersen, T.; Bergamaschi, R.; Giuliani, G.; Boz, C.; Coniglio, G.; Van, V.
Journal:
Acta neurologica Scandinavica
Issue:
Volume 127:Number 5(2013:May)
Page Start:
301
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis. (19th January 2016)

Authors:
Spelman, T.; Mekhael, L.; Burke, T.; Butzkueven, H.; Hodgkinson, S.; Havrdova, E.; Horakova, D.; Duquette, P.; Izquierdo, G.; Grand'Maison, F.; Grammond, P.; Barnett, M.; Lechner‐Scott, J.; Alroughani, R.; Trojano, M.; Lugaresi, A.; Granella, F.; Pucci, E.; Vucic, S.
Journal:
European journal of neurology
Issue:
Volume 23:Number 4(2016:Apr.)
Page Start:
729
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The clinical and cost impact of switching to fingolimod versus other first line injectable disease-modifying therapies in patients with relapsing multiple sclerosis. (4th May 2019)

Authors:
Freedman, M. S.; Duquette, P.; Grand'Maison, F.; Lee, L.; Vorobeychik, G.; Lara, N.; Khurana, V.; Nakhaipour, H. R.; Schecter, R.; Haddad, P.
Journal:
Current medical research and opinion
Issue:
Volume 35:Number 5(2019)
Page Start:
767
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗